Hannah Y Wen Selected Research

Hannah Y Wen Research Topics

Disease

30	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2015
27	Neoplasms (Cancer) 12/2023 - 01/2015
7	Triple Negative Breast Neoplasms 06/2023 - 01/2016
5	Carcinoma (Carcinomatosis) 12/2022 - 07/2019
3	Lobular Carcinoma 02/2024 - 09/2017
3	Disease Progression 07/2021 - 01/2019
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 07/2019 - 08/2017
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 12/2020
2	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2021 - 01/2017
2	Papillary Carcinoma 01/2020 - 08/2017
2	Acinar Cell Carcinoma 12/2019 - 01/2017
2	Pathologic Complete Response 08/2019 - 09/2017
2	Lymphatic Metastasis 01/2018 - 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2023
1	Adenoid Cystic Carcinoma (Cylindroma) 08/2022
1	Brain Neoplasms (Brain Tumor) 03/2022
1	Fibroadenoma 02/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022
1	Small Cell Carcinoma 10/2021
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021
1	Bites and Stings (Sting) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Infections 01/2020
1	Intraductal Papilloma 01/2020
1	Fatigue 01/2020
1	Adenomyoepithelioma 01/2018
1	Adenocarcinoma 08/2017
1	Carcinogenesis 03/2016

Drug/Important Bio-Agent (IBA)

15	Estrogen ReceptorsIBA 01/2023 - 01/2016
6	human ERBB2 proteinIBA 03/2021 - 03/2016
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 01/2019
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
4	Hormones (Hormone)IBA 12/2022 - 01/2020
3	Cadherins (E-Cadherin)IBA 02/2024 - 01/2018
3	B7-H1 AntigenIBA 01/2022 - 01/2020
3	RNA (Ribonucleic Acid)IBA 12/2019 - 03/2016
2	ChromatinIBA 10/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2017
2	MucinsIBA 07/2019 - 01/2019
1	Coloring Agents (Dyes)IBA 12/2022
1	Trastuzumab (Herceptin)FDA Link 03/2022
1	pertuzumabIBA 03/2022
1	Mediator ComplexIBA 02/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	EpitopesIBA 01/2022
1	Adenosine Triphosphatases (ATPase)IBA 10/2021
1	atezolizumabIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Dihydrotachysterol (AT 10)IBA 12/2020
1	pembrolizumabIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	AntibodiesIBA 01/2020
1	Checkpoint Kinase 2IBA 06/2019
1	AntigensIBA 01/2019
1	LigandsIBA 01/2019
1	Codon (Codons)IBA 01/2018
1	erucylphosphocholineIBA 08/2017
1	ParaffinIBA 03/2017
1	Formaldehyde (Formol)FDA Link 03/2017
1	Complex MixturesIBA 03/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	Mitogen-Activated Protein KinasesIBA 03/2016
1	Tetracycline (Achromycin)FDA LinkGeneric 03/2016
1	Phenobarbital (Luminal)FDA Link 01/2016

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 12/2023 - 08/2017
7	Neoadjuvant Therapy 08/2022 - 09/2017
7	Therapeutics 01/2022 - 03/2016
4	Immunotherapy 01/2022 - 01/2021
3	Radiotherapy 06/2023 - 01/2020
2	Segmental Mastectomy (Lumpectomy) 07/2021 - 01/2021
1	Precision Medicine 12/2023
1	Genomic Medicine 01/2023
1	Adjuvant Chemotherapy 01/2017